Cancer (Oncology)

Abirapro 250® Abiraterone Acetate Tablets
Abiraterone Acetate 250mg
- Composition
- Abiraterone Acetate 250mg
- Dosage form
- Tablet
- Pack size
- Bottle of 120 Tablet
- Manufacturer
- Glenmark Pharmaceuticals
- Also known as
- Zytiga
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Abirapro 250 mg contains abiraterone acetate and is used to treat certain forms of advanced prostate cancer, including metastatic castration-resistant prostate cancer and selected metastatic hormone-sensitive prostate cancer
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →